FR2392998B1 - - Google Patents

Info

Publication number
FR2392998B1
FR2392998B1 FR7816626A FR7816626A FR2392998B1 FR 2392998 B1 FR2392998 B1 FR 2392998B1 FR 7816626 A FR7816626 A FR 7816626A FR 7816626 A FR7816626 A FR 7816626A FR 2392998 B1 FR2392998 B1 FR 2392998B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7816626A
Other versions
FR2392998A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2392998A1 publication Critical patent/FR2392998A1/fr
Application granted granted Critical
Publication of FR2392998B1 publication Critical patent/FR2392998B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
FR7816626A 1977-06-03 1978-06-02 Procede de preparation de composes de b-lactame et nouveaux produits ainsi obtenus Granted FR2392998A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6599077A JPS543087A (en) 1977-06-03 1977-06-03 Preparation of cephalosporin compound

Publications (2)

Publication Number Publication Date
FR2392998A1 FR2392998A1 (fr) 1978-12-29
FR2392998B1 true FR2392998B1 (fr) 1982-10-22

Family

ID=13302946

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7816626A Granted FR2392998A1 (fr) 1977-06-03 1978-06-02 Procede de preparation de composes de b-lactame et nouveaux produits ainsi obtenus

Country Status (6)

Country Link
US (1) US4246405A (fr)
JP (1) JPS543087A (fr)
DE (1) DE2824004A1 (fr)
FR (1) FR2392998A1 (fr)
GB (1) GB1599559A (fr)
IT (1) IT1098302B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393059A (en) * 1977-03-14 1983-07-12 Fujisawa Pharmaceutical Company, Limited Cephem compounds
US4372952A (en) * 1978-07-31 1983-02-08 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4402803A (en) * 1981-09-14 1983-09-06 Eli Lilly And Company Process for 3-hydrogen cephems
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
JPH0474917U (fr) * 1990-11-09 1992-06-30
JP4510957B2 (ja) * 1999-09-01 2010-07-28 大塚化学株式会社 セフェム化合物の製造方法
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013651A (en) * 1975-05-12 1977-03-22 Eli Lilly And Company 3-substituted amino-cephalosporins
JPS5259186A (en) * 1975-11-11 1977-05-16 Shionogi & Co Ltd Preparation of 3-cephem compounds by reduction

Also Published As

Publication number Publication date
FR2392998A1 (fr) 1978-12-29
GB1599559A (en) 1981-10-07
JPS624394B2 (fr) 1987-01-30
JPS543087A (en) 1979-01-11
IT7824181A0 (it) 1978-06-02
IT1098302B (it) 1985-09-07
DE2824004A1 (de) 1978-12-14
US4246405A (en) 1981-01-20

Similar Documents

Publication Publication Date Title
DE2725135C2 (fr)
DE2759049C3 (fr)
DE2750384C2 (fr)
AU71461S (fr)
BE851449A (fr)
BE865722A (fr)
BE866391A (fr)
BE868323A (fr)
BE870787A (fr)
BE871419A (fr)
BE871991A (fr)
BE872973A (fr)
BE873002A (fr)
BG23438A1 (fr)
BG23462A1 (fr)
BG24331A1 (fr)
BG24713A1 (fr)
BG25808A1 (fr)
BG25809A1 (fr)
BG25810A1 (fr)
BG25811A1 (fr)
BG25812A1 (fr)
BG25813A1 (fr)
BG25815A1 (fr)
BG25819A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse